The global pharmaceutical landscape is undergoing a structural shift. For decades, the commercial model relied on field representatives visiting clinics, waiting in corridors and securing face-to-face time with Healthcare Professionals (HCPs). Today, that playbook is losing its efficacy.
Strict health system policies, overloaded schedules and geographical dispersion have created vast zones where traditional detailing is no longer viable. IQVIA's Launch Excellence IX reports that in six of the eight largest pharma markets, interactive pharma–HCP engagements at the end of 2024 remained significantly below pre-pandemic levels, as overstretched doctors have limited capacity to meet multiple reps. [1]
Pushing traditional detailing into restricted or remote geographies leads to burnt-out reps, inflated travel budgets and falling return on investment (ROI). Organizations must rethink Pharmaceutical Sales Territory Management for hard-to-reach medical communities.
The Access Crisis: Why Traditional Sales Models Are Faltering
The decline in physical access is a permanent shift driven by broader Pharmaceutical Market Access Challenges: hospital consolidation, compliance rules and intense patient workloads.
Rep Travels Hours → Long Waiting Room Stay → Brief/Canceled Meeting → Low ROI
AI Insights → Targeted Remote Touchpoint → High-Value Digital Engagement → Optimized ROI
In remote regions, distance compounds these constraints: reps drive hours only to face a cancelled meeting or a thirty-second hallway discussion.
The challenge is especially sharp in Pakistan. The 2023 census found that around 61% of the country's 241.49 million people live in rural areas, [2] while the Pakistan Economic Survey 2024–25 counts 319,572 registered doctors nationwide, [3] roughly one for every 750 people. Relying solely on in-person visits for Reaching Hard-to-Access Doctors drains productivity and leaves clinical insights uncommunicated.
The Human and Productivity Cost of Outdated Territory Strategies
When reps cover impossible geographies under legacy metrics such as calls per day, three problems emerge:
- Field Force Fatigue and Burnout: Hours behind the wheel instead of clinical discussions reduce job satisfaction and drive turnover among top talent.
- Wasted Operational Spend: Mileage, overnight stays and unproductive transit erode the margins of regional launches.
- Unequal Health Information Distribution: Doctors in remote areas miss new treatment paradigms, real-world evidence and dosing updates, indirectly affecting patient care.
Redefine Reach with Hybrid and Digital-First Engagement Models
Successful teams move beyond the choice between in-person meetings and cold digital outreach, building workflows around Digital HCP Engagement Strategies.
1. The Power of Remote HCP Engagement
Remote HCP Engagement replaces long, low-yield drives with virtual interactions, and meetings requested by the physician often produce better discussions than hallway drop-ins. In Pakistan, the infrastructure is in place: the Pakistan Telecommunication Authority reports over 150 million broadband connections and telecom coverage above 92%. [4]
2. Multi-Channel Nurture Sequences
Doctors in low-access areas rarely keep a 9-to-5 schedule, so asynchronous Digital Communication for Pharmaceutical Companies matters, and so does the channel. In a national survey of 718 Pakistani physicians, WhatsApp was the most common pharma digital channel doctors received (29.9%), far ahead of e-detailing (8.1%) and email (4.2%). [5]
This is the model behind WaaPharma, a WhatsApp-based clinical AI platform for pharmaceutical companies. After a single invite from their rep, doctors in any territory can ask about a company's portfolio, dosing, interactions, evidence or guidelines at any hour, and receive answers drawn only from approved content, with no app to download or login to remember.
Scaling Precision via AI-Powered Doctor Engagement
Modern engagement needs intelligent workflows that help reps prioritize and personalize outreach. This is where AI-Powered Doctor Engagement transforms commercial operations.
Machine learning gives field forces predictive insights:
- Next-Best-Action Suggestions: AI suggests the optimal time, channel and clinical topic for each hard-to-reach doctor.
- Behavioral Segmentation: Algorithms identify who prefers face-to-face visits, short virtual updates or medical science liaisons (MSLs).
- Dynamic Territory Adjustments: Managers can adjust territories and target lists in real time rather than in static annual reviews.
The results can be significant. McKinsey's analysis of omnichannel models in Asia found that well-executed transformations delivered a 5–10% revenue uplift and a 3–5% increase in prescribers. [6] Integrated tooling directly enhances Pharma Field Force Optimization.
Action Plan: Modernizing HCP Outreach in Underserved Areas
Improving HCP Engagement in Low-Access Territories requires a systematic approach.
Step 1: Conduct a Comprehensive Access Audit
Map territory performance against access metrics and travel-time-to-meeting ratios, then group territories:
- High-Access: Maintain optimized face-to-face coverage.
- Hybrid-Access: Deploy balanced physical and digital workflows.
- Low/No-Access: Shift to digital-first, remote-led engagement.
Step 2: Equip Teams for Seamless Digital Communication
Give reps the training and tools to deliver value remotely:
- Compliant, rep-triggered tools that send approved follow-up materials instantly. In Pakistan, these must align with DRAP's Ethical Marketing to Healthcare Professionals Rules, 2021. [7]
- Interactive digital detailers optimized for mobile screens.
- Bite-sized content modules designed for quick virtual reviews.
Step 3: Realign Key Performance Indicators (KPIs)
If success is measured by call volume alone, reps will keep driving for low-yield visits. Instead:
- Measure meaningful touchpoints across physical and digital channels.
- Track HCP digital content engagement and video meeting completion rates.
- Reward adoption of data-driven next-best-action recommendations.
Step 4: Foster a Culture of Continuous Experimentation
Encourage reps to share successful remote tactics, and highlight cases where hybrid outreach unlocked previously non-responsive physicians.
The Road Ahead: Turning Access Challenges into Operational Strengths
Forward-thinking companies treat restricted access as a catalyst to modernize. By measuring productivity in meaningful interactions rather than miles driven, they build resilient sales models and ensure doctors everywhere get the clinical insights they need.
For teams ready to make that shift, WaaPharma turns WhatsApp into a governed channel for hard-to-reach doctors. Complex or off-label queries escalate to Medical Affairs, and every query, sample request and escalation appears on a real-time dashboard by region and product. Book a demo with WaaPharma to see it live in as little as 48 hours.
Reach Doctors Beyond Traditional Field Visits
See how WaaPharma supports approved medical information access and engagement through WhatsApp, including in low-access territories.
Book a DemoFrequently Asked Questions
What is a low-access territory in pharma?
A region where reps struggle to meet doctors in person because of restrictive policies, heavy workloads or long travel distances.
How can pharma reach doctors in remote areas of Pakistan?
By combining targeted visits with digital channels doctors already use, especially WhatsApp, the most common pharma digital channel in a national survey of Pakistani physicians.
How does AI improve pharma territory management?
Next-best-action tools suggest the right time, channel and topic for each doctor, and help managers adjust territories dynamically.
How does WaaPharma help in low-access territories?
Doctors anywhere can ask product questions on WhatsApp 24/7 and get answers from approved content, while teams track engagement by region on a real-time dashboard.
References
- Rickwood S, Scott K, Agarwal M, Alzaga-Chaudhry C. Launch Excellence IX: Embracing change and unlocking efficiency. IQVIA white paper. June 2025.
- Dawn. Population surpasses 240m, new census shows. August 6, 2023.
- Finance Division, Government of Pakistan. Pakistan Economic Survey 2024–25, Chapter 11: Health and Nutrition.
- Pakistan Telecommunication Authority. PTA releases Annual Report 2024–25. December 31, 2025.
- Pharmaceutical digital marketing and its impact on healthcare physicians of Pakistan: a national survey. Cureus. 2018.
- Chan R, Kim M, Le Deu F, Li L. Demystifying the omnichannel commercial model for pharma companies in Asia. McKinsey & Company. January 2022.
- Drug Regulatory Authority of Pakistan. Ethical Marketing to Healthcare Professionals Rules, 2021 (S.R.O. 1472(I)/2021).